News & Updates
Showing Paediatrics articles
Showing

Lebrikizumab–topical corticosteroid combo improves outcomes in moderate-to-severe AD
Treatment with lebrikizumab, when combined with low- to mid-potency topical corticosteroid (TCS), helps reduce disease severity in adolescent and adult patients with moderate-to-severe atopic dermatitis (AD), with a safety profile consistent with that reported in previous AD studies, according to the phase III ADhere trial.

Modified Atkins diet helps control drug-resistant epilepsy
Teen and adult patients with drug-resistant epilepsy may benefit from modified Atkins diet, which has been shown in a recent study to produce improvements in seizure frequency, quality of life (QOL), and behavioural problems as compared with standard drug therapy.

Farm life safeguards children against allergic rhinitis
Growing up on a farm appears to confer a reduced risk of developing allergic rhinitis in children, with the protective effect of farm living being set until school age and sustained through early adulthood.





